These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34379296)

  • 1. Utility of TMPRSS4 as a Prognostic Biomarker and Potential Therapeutic Target in Patients with Gastric Cancer.
    Tazawa H; Suzuki T; Saito A; Ishikawa A; Komo T; Sada H; Shimada N; Hadano N; Onoe T; Sudo T; Shimizu Y; Kuraoka K; Tashiro H
    J Gastrointest Surg; 2022 Feb; 26(2):305-313. PubMed ID: 34379296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of transmembrane serine protease 4 on the survival in patients with pancreatic ductal adenocarcinoma undergoing surgery followed by adjuvant chemotherapy.
    Tazuma S; Sudo T; Ishikawa A; Yamaguchi A; Shibata Y; Ishida Y; Kuraoka K; Uemura K; Takahashi S; Tashiro H
    Surg Today; 2024 Oct; 54(10):1208-1219. PubMed ID: 38637344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of TMPRSS4 in gastric cancer.
    Sheng H; Shen W; Zeng J; Xi L; Deng L
    Neoplasma; 2014; 61(2):213-7. PubMed ID: 24299317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of TMPRSS4 and Erk1 correlates with metastasis and poor prognosis in Chinese patients with gastric cancer.
    Luo ZY; Wang YY; Zhao ZS; Li B; Chen JF
    PLoS One; 2013; 8(7):e70311. PubMed ID: 23922976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMPRSS4 promotes invasiveness of human gastric cancer cells through activation of NF-κB/MMP-9 signaling.
    Jin J; Shen X; Chen L; Bao LW; Zhu LM
    Biomed Pharmacother; 2016 Feb; 77():30-6. PubMed ID: 26796262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of TMPRSS4 in prostate cancer.
    Shi G; Yang X; Dai B; Zhang H; Shen Y; Zhu Y; Zhu Y; Xiao W; Ma C; Wen L; Qin X; Cao D; Ye D
    Int J Clin Exp Pathol; 2014; 7(11):8053-8. PubMed ID: 25550850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMPRSS4 is a novel biomarker and correlated with immune infiltration in thyroid carcinoma.
    Xu X; Sun T; Jing J
    BMC Endocr Disord; 2022 Nov; 22(1):280. PubMed ID: 36380313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression level of TMPRSS4 predicts adverse outcomes of colorectal cancer patients.
    Huang A; Zhou H; Zhao H; Quan Y; Feng B; Zheng M
    Med Oncol; 2013 Dec; 30(4):712. PubMed ID: 24072509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane serine protease 4 expression in the prognosis of radical resection for biliary tract cancer.
    Shibata Y; Sudo T; Tazuma S; Tanimine N; Onoe T; Shimizu Y; Yamaguchi A; Kuraoka K; Takahashi S; Tashiro H
    World J Gastrointest Surg; 2024 Aug; 16(8):2555-2564. PubMed ID: 39220090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients.
    Villalba M; Diaz-Lagares A; Redrado M; de Aberasturi AL; Segura V; Bodegas ME; Pajares MJ; Pio R; Freire J; Gomez-Roman J; Montuenga LM; Esteller M; Sandoval J; Calvo A
    Oncotarget; 2016 Apr; 7(16):22752-69. PubMed ID: 26989022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMPRSS4 as an emerging potential poor prognostic factor for solid tumors: A systematic review and meta-analysis.
    Zeng P; Zhang P; Zhou LN; Tang M; Shen YX; Jin J; Zhu YQ; Chen MB
    Oncotarget; 2016 Nov; 7(46):76327-76336. PubMed ID: 27344186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TMPRSS4 Expression as a Marker of Recurrence in Patients with Lung Cancer.
    Chikaishi Y; Uramoto H; Koyanagi Y; Yamada S; Yano S; Tanaka F
    Anticancer Res; 2016 Jan; 36(1):121-7. PubMed ID: 26722035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High TMPRSS4 expression is a predictor of poor prognosis in cervical squamous cell carcinoma.
    Cheng D; Liang B; Li Y
    Cancer Epidemiol; 2013 Dec; 37(6):993-7. PubMed ID: 24012692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of TMPRSS4 promotes tumor proliferation and aggressiveness in breast cancer.
    Li XM; Liu WL; Chen X; Wang YW; Shi DB; Zhang H; Ma RR; Liu HT; Guo XY; Hou F; Li M; Gao P
    Int J Mol Med; 2017 Apr; 39(4):927-935. PubMed ID: 28259959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of TMPRSS4 expression in patients with breast cancer.
    Liang B; Wu M; Bu Y; Zhao A; Xie F
    Med Oncol; 2013 Jun; 30(2):497. PubMed ID: 23420063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMPRSS4 as a poor prognostic factor for triple-negative breast cancer.
    Cheng D; Kong H; Li Y
    Int J Mol Sci; 2013 Jul; 14(7):14659-68. PubMed ID: 23857060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1.
    Lee Y; Yoon J; Ko D; Yu M; Lee S; Kim S
    J Exp Clin Cancer Res; 2021 Nov; 40(1):372. PubMed ID: 34809669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer.
    Kim S
    Exp Mol Med; 2023 Apr; 55(4):716-724. PubMed ID: 37009799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMPRSS4 correlates with colorectal cancer pathological stage and regulates cell proliferation and self-renewal ability.
    Huang A; Zhou H; Zhao H; Quan Y; Feng B; Zheng M
    Cancer Biol Ther; 2014 Mar; 15(3):297-304. PubMed ID: 24335200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMPRSS4 overexpression promotes the metastasis of colorectal cancer and predicts poor prognosis of stage III-IV colorectal cancer.
    Zhao XF; Yang YS; Gao DZ; Park YK
    Int J Biol Markers; 2021 Sep; 36(3):23-32. PubMed ID: 34595980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.